Loss of Med1/TRAP220 promotes the invasion and metastasis of human non-small-cell lung cancer cells by modulating the expression of metastasis-related genes

Cancer Letters

Volumn 321, Issue 2, 2012, Pages 195-202

  Kim, Hyun Ju ^a   Roh, Mee Sook ^a   Son, Choon Hee ^a   Kim, Ae Jeong ^a   Jee, Hye Jin ^a   Song, Naree ^a   Kim, Minjee ^a   Seo, Su Young ^a   Yoo, Young Hyun ^a   Yun, Jeanho ^a  

^a Dong A University   (South Korea)

Author keywords

Invasion; Med1; Metastasis; Non small cell lung cancer; Transcription regulation

Indexed keywords

MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INVASION; CANCER PATIENT; DISEASE ACTIVITY; GENE; GENE EXPRESSION; HOXA4 GENE; ID2 GENE; ID4 GENE; IN VIVO STUDY; LUNG NON SMALL CELL CANCER; METASTASIS; MICROARRAY ANALYSIS; NONHUMAN; PKP3 GENE; PLD1 GENE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN FUNCTION; PTP4A1 GENE; RGS2 GENE; TGM2 GENE; TIMP2 GENE; TUMOR XENOGRAFT; UPAR GENE;

ANIMALS; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MEDIATOR COMPLEX SUBUNIT 1; MICE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 84862811748     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2012.02.009     Document Type: Article

References (39)

1. Jemal A., Siegel R., Ward E., Murray T., Xu J., Smigal C., Thun M.J. Cancer statistics, 2006. CA Cancer J. Clin. 2006, 56:106-130.
2. Soon Y.Y., Stockler M.R., Askie L.M., Boyer M.J. Duration of chemotherapy for advanced non-small-cell lung cancer: a systematic review and meta-analysis of randomized trials. J. Clin. Oncol. 2009, 27:3277-3283.
3. Williams M.D., Sandler A.B. The epidemiology of lung cancer. Cancer Treat. Res. 2001, 105:31-52.
4. Ito M., Roeder R.G. The TRAP/SMCC/Mediator complex and thyroid hormone receptor function. Trends Endocrinol. Metab. 2001, 12:127-134.
5. Malik S., Guermah M., Yuan C.X., Wu W., Yamamura S., Roeder R.G. Structural and functional organization of TRAP220, the TRAP/mediator subunit that is targeted by nuclear receptors. Mol. Cell. Biol. 2004, 24:8244-8254.
6. Kang Y.K., Guermah M., Yuan C.X., Roeder R.G. The TRAP/Mediator coactivator complex interacts directly with estrogen receptors alpha and beta through the TRAP220 subunit and directly enhances estrogen receptor function in vitro. Proc. Natl. Acad. Sci. USA 2002, 99:2642-2647.
7. Yuan C.X., Ito M., Fondell J.D., Fu Z.Y., Roeder R.G. The TRAP220 component of a thyroid hormone receptor-associated protein (TRAP) coactivator complex interacts directly with nuclear receptors in a ligand-dependent fashion. Proc. Natl. Acad. Sci. USA 1998, 95:7939-7944.
8. Frade R., Balbo M., Barel M. RB18A regulates p53-dependent apoptosis. Oncogene 2002, 21:861-866.
9. Wada O., Oishi H., Takada I., Yanagisawa J., Yano T., Kato S. BRCA1 function mediates a TRAP/DRIP complex through direct interaction with TRAP220. Oncogene 2004, 23:6000-6005.
10. Vijayvargia R., May M.S., Fondell J.D. A coregulatory role for the mediator complex in prostate cancer cell proliferation and gene expression. Cancer Res. 2007, 67:4034-4041.
11. Zhu Y., Qi C., Jain S., Le Beau M.M., Espinosa R., Atkins G.B., Lazar M.A., Yeldandi A.V., Rao M.S., Reddy J.K. Amplification and overexpression of peroxisome proliferator-activated receptor binding protein (PBP/PPARBP) gene in breast cancer. Proc. Natl. Acad. Sci. USA 1999, 96:10848-10853.
12. Ndong Jde L., Jean D., Rousselet N., Frade R. Down-regulation of the expression of RB18A/MED1, a cofactor of transcription, triggers strong tumorigenic phenotype of human melanoma cells. Int. J. Cancer 2009, 124:2597-2606.
13. Yun J., Son C.H., Um S.J., Kwon H.C., Lee K.E., Choi P.J., Roh M.S. A different TRAP220 expression in distinct histologic subtypes of lung adenocarcinoma and the prognostic significance. Lung Cancer 2011, 71:312-318.
14. Kim A.J., Kim H.J., Jee H.J., Song N., Kim M., Bae Y.S., Chung J.H., Yun J. Glucose deprivation is associated with Chk1 degradation through the ubiquitin-proteasome pathway and effective checkpoint response to replication blocks. Biochim. Biophys. Acta 1813, 2011:1230-1238.
15. Klein C.A. Cancer: The metastasis cascade. Science 2008, 321:1785-1787.
16. Zhu Y., Qi C., Jia Y., Nye J.S., Rao M.S., Reddy J.K. Deletion of PBP/PPARBP, the gene for nuclear receptor coactivator peroxisome proliferator-activated receptor-binding protein, results in embryonic lethality. J. Biol. Chem. 2000, 275:14779-14782.
17. Matsumoto K., Yu S., Jia Y., Ahmed M.R., Viswakarma N., Sarkar J., Kashireddy P.V., Rao M.S., Karpus W., Gonzalez F.J., Reddy J.K. Critical role for transcription coactivator peroxisome proliferator-activated receptor (PPAR)-binding protein/TRAP220 in liver regeneration and PPARalpha ligand-induced liver tumor development. J. Biol. Chem. 2007, 282:17053-17060.
18. Ge K., Guermah M., Yuan C.X., Ito M., Wallberg A.E., Spiegelman B.M., Roeder R.G. Transcription coactivator TRAP220 is required for PPAR gamma 2-stimulated adipogenesis. Nature 2002, 417:563-567.
19. Nguyen D.X., Bos P.D., Massague J. Metastasis: from dissemination to organ-specific colonization. Nat. Rev. Cancer 2009, 9:274-284.
20. Smith H.W., Marshall C.J. Regulation of cell signalling by uPAR. Nat. Rev. Mol. Cell. Biol. 2010, 11:23-36.
21. Coma S., Amin D.N., Shimizu A., Lasorella A., Iavarone A., Klagsbrun M. Id2 promotes tumor cell migration and invasion through transcriptional repression of semaphorin 3F. Cancer Res. 2010, 70:3823-3832.
22. Yuen H.F., Chua C.W., Chan Y.P., Wong Y.C., Wang X., Chan K.W. Id proteins expression in prostate cancer: high-level expression of Id-4 in primary prostate cancer is associated with development of metastases. Mod. Pathol. 2006, 19:931-941.
23. Zeng Q., Dong J.M., Guo K., Li J., Tan H.X., Koh V., Pallen C.J., Manser E., Hong W. PRL-3 and PRL-1 promote cell migration, invasion, and metastasis. Cancer Res. 2003, 63:2716-2722.
24. Furukawa C., Daigo Y., Ishikawa N., Kato T., Ito T., Tsuchiya E., Sone S., Nakamura Y. Plakophilin 3 oncogene as prognostic marker and therapeutic target for lung cancer. Cancer Res. 2005, 65:7102-7110.
25. Mehta K., Fok J., Miller F.R., Koul D., Sahin A.A. Prognostic significance of tissue transglutaminase in drug resistant and metastatic breast cancer. Clin. Cancer Res. 2004, 10:8068-8076.
26. Kang D.W., Park M.H., Lee Y.J., Kim H.S., Lindsley C.W., Alex Brown H., Min do S. Autoregulation of phospholipase D activity is coupled to selective induction of phospholipase D1 expression to promote invasion of breast cancer cells. Int. J. Cancer 2011, 128:805-816.
27. Preissner K.T., Kanse S.M., May A.E. Urokinase receptor: a molecular organizer in cellular communication. Curr. Opin. Cell Biol. 2000, 12:621-628.
28. Fontemaggi G., Dell'Orso S., Trisciuoglio D., Shay T., Melucci E., Fazi F., Terrenato I., Mottolese M., Muti P., Domany E., Del Bufalo D., Strano S., Blandino G. The execution of the transcriptional axis mutant p53, E2F1 and ID4 promotes tumor neo-angiogenesis. Nat. Struct. Mol. Biol. 2009, 16:1086-1093.
29. Meng Y., Gu C., Wu Z., Zhao Y., Si Y., Fu X., Han W. Id2 promotes the invasive growth of MCF-7 and SKOV-3 cells by a novel mechanism independent of dimerization to basic helix-loop-helix factors. BMC Cancer 2009, 9:75.
30. Fiordalisi J.J., Keller P.J., Cox A.D. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility. Cancer Res. 2006, 66:3153-3161.
31. Li Z., Xu X., Bai L., Chen W., Lin Y. Epidermal growth factor receptor-mediated tissue transglutaminase overexpression couples acquired tumor necrosis factor-related apoptosis-inducing ligand resistance and migration through c-FLIP and MMP-9 proteins in lung cancer cells. J. Biol. Chem. 2011, 286:21164-21172.
32. Kim J.H., Kim H.W., Jeon H., Suh P.G., Ryu S.H. Phospholipase D1 regulates cell migration in a lipase activity-independent manner. J. Biol. Chem. 2006, 281:15747-15756.
33. Jiang Z., Wang Z., Xu Y., Wang B., Huang W., Cai S. Analysis of RGS2 expression and prognostic significance in stage II and III colorectal cancer. Biosci. Rep. 2010, 30:383-390.
34. Kawamata H., Kawai K., Kameyama S., Johnson M.D., Stetler-Stevenson W.G., Oyasu R. Over-expression of tissue inhibitor of matrix metalloproteinases (TIMP1 and TIMP2) suppresses extravasation of pulmonary metastasis of a rat bladder carcinoma. Int. J. Cancer 1995, 63:680-687.
35. Ota T., Klausen C., Salamanca M.C., Woo H.L., Leung P.C., Auersperg N. Expression and function of HOXA genes in normal and neoplastic ovarian epithelial cells. Differentiation 2009, 77:162-171.
36. Rigg A.S., Lemoine N.R. Adenoviral delivery of TIMP1 or TIMP2 can modify the invasive behavior of pancreatic cancer and can have a significant antitumor effect in vivo. Cancer Gene. Ther. 2001, 8:869-878.
37. Brew K., Nagase H. The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. Biochim. Biophys. Acta 1803, 2010:55-71.
38. Klausen C., Leung P.C., Auersperg N. Cell motility and spreading are suppressed by HOXA4 in ovarian cancer cells: possible involvement of beta1 integrin. Mol. Cancer Res. 2009, 7:1425-1437.
39. Gade P., Singh A.K., Roy S.K., Reddy S.P., Kalvakolanu D.V. Down-regulation of the transcriptional mediator subunit Med1 contributes to the loss of expression of metastasis-associated dapk1 in human cancers and cancer cells. Int. J. Cancer 2009, 125:1566-1574.